コーパス検索結果 (left1)
通し番号をクリックするとPubMedの該当ページを表示します
1 ER alpha activation of mGluR1a is dependent on CAV1, whe
2 ER alpha and ER beta agonists PPT and DPN inhibited and
3 ER alpha binds to a potential Stat5a ERE.
4 ER alpha mRNA was expressed more abundantly on EPCs comp
5 ER alpha plays a more prominent role in this process.
6 ER alpha signals through multiple pathways, which can be
7 ER alpha t(1/2) was reduced in ER alpha-negative cell li
8 ER alpha-negative primary breast cancers and cell lines
9 ER-alpha did not repress transcription of an HBV replico
10 ER-alpha expression may be regulated in melanoma via hyp
11 ER-alpha methylation status in tumor (n = 107) and sera
12 ER-alpha was methylated more frequently in metastatic th
14 lar cross-talks and side-talks among IGF-1R, ER-alpha, and phosphatidylinositol 3-kinase (PI3K)/Akt s
15 able and overlapping ESR1 mRNA levels in 200 ER alpha-negative and 50 ER alpha-positive primary breas
16 mRNA levels in 200 ER alpha-negative and 50 ER alpha-positive primary breast cancers examined, which
17 premalignant (EIII8) or tumorigenic (MCF-7), ER-alpha(+) tamoxifen-resistant (EIII8-TAM(R)) or ER-alp
18 s suggest that 3MC and PCB directly activate ER alpha, and this was confirmed in a competitive ER alp
19 ults show that PCB and 3MC directly activate ER alpha-dependent transactivation and extend the number
21 y proliferation, but also estrogen-activated ER alpha loss in a subset of ER alpha-negative breast ca
23 Inducible Src stimulated ligand-activated ER alpha transcriptional activity and reduced ER alpha t
26 Nuclear receptor estrogen receptor alpha (ER alpha) controls the expression of hundreds of genes r
28 ranslocation of the estrogen receptor alpha (ER alpha) have been described, but the mechanisms releva
34 interaction between estrogen receptor alpha (ER alpha), caveolin-1 (Cav-1) and c-Src, and increased p
38 membrane-associated estrogen receptor-alpha (ER alpha) led to activation of metabotropic glutamate re
39 ulation by siRNA of estrogen receptor-alpha (ER alpha), but not ER beta, inhibited estrogen-stimulate
40 ever, the roles of estrogen receptors alpha (ER alpha) and beta (ER beta) in EPC biology are largely
41 n receptor (AR) and estrogen receptor alpha (ER-alpha) activity is higher in digit 4 than in digit 2.
43 aromatase, bind to estrogen receptor alpha (ER-alpha) and estrogen receptor beta (ER-beta), and anta
44 tradiol (E2)-bound oestrogen receptor alpha (ER-alpha) causes a global increase in eRNA transcription
47 E2 treatment of the estrogen receptor alpha (ER-alpha) negative MCF-10F cell line on the in vitro exp
48 breast cancers are estrogen receptor alpha (ER-alpha) positive, and although women typically initial
50 re mediated via the estrogen receptor alpha (ER-alpha), the existence of another novel ER, G protein-
51 uced recruitment to estrogen receptor alpha (ER-alpha)-bound eRNA(+) active enhancers in interphase b
55 in the function of estrogen receptor-alpha (ER-alpha) as assessed by serine 305 (S305) activation an
56 In rat hippocampus, estrogen receptor-alpha (ER-alpha) can initiate nongenomic signaling mechanisms t
58 involvement of the estrogen receptor-alpha (ER-alpha) in locomotor recovery, is still a subject of m
59 through decreasing estrogen receptor-alpha (ER-alpha) level when cultured with luminal BrCA cell lin
61 nd to interact with estrogen receptor-alpha (ER-alpha), and HE4 overexpression resulted in ER-alpha d
62 ck of expression of estrogen receptor-alpha (ER-alpha), progesterone receptor (PR), and human epiderm
67 (<2 nm) to lower affinity complexes with an ER alpha monomer at higher SRC-RID concentrations (appro
68 A Notch mimetic peptide could activate an ER-alpha promoter reporter in a BRCA1-dependent manner,
69 nsylcadaverine, and proteolysis of BSA in an ER-alpha dependent manner, and increased resistance to 4
74 o be a novel link between Src activation and ER alpha proteolysis and support a model whereby crossta
77 educed sensitivity to U0126 or LY294002, and ER-alpha hyperphosphorylation in the activation function
80 ins in cerebrovascular mitochondria, such as ER-alpha, cytochrome c, subunit IV of complex IV, and ma
82 itation assays showed an interaction between ER-alpha and HNF-4alpha; this interaction prevented HNF-
88 involves selective trimming of N-glycans by ER alpha-mannosidase I and subsequent recognition by the
95 pha, and this was confirmed in a competitive ER alpha binding assay and in a fluorescence resonance e
96 I8-Tam(R) cells correlated with constitutive ER-alpha hyperphosphorylation that was unaffected by the
97 owever, the mean size of synapses containing ER-alpha was larger than that of unlabeled excitatory sy
98 percentage of excitatory synapses containing ER-alpha, nor were there any group differences in distri
99 e differentially associated with cytoplasmic ER-alpha and/or nuclear ER-beta expression-defined NSCLC
100 er (SERD) that both antagonizes and degrades ER-alpha and is active in patients who have progressed o
102 regulation involving AP1 motifs that direct ER alpha-DNA interaction is required to increase Igf1 tr
104 act within the same neuron through divergent ER alpha signaling pathways to regulate different neurot
105 alk between liganded ER alpha and Src drives ER alpha transcriptional activity and targets ER alpha f
108 unoprecipitation assay, PCB and 3MC enhanced ER alpha (but not AhR) association with the estrogen-res
109 crystal structures of the main ERQC enzyme, ER alpha-glucosidase II (alpha-GluII; from mouse), alone
111 munolabeling for androgen (AR) and estrogen (ER alpha) receptors revealed no colocalization of hcrt/o
112 to triple-negative ones that do not express ER-alpha- and Her-2 and are highly tumorigenic in xenogr
113 with AR and few hcrt/orx neurons expressing ER alpha, suggesting that hormonal regulation of hcrt/or
114 postnatal days (PNDs) 0, 2, 4, 7, and 19 for ER alpha (ERalpha; Esr1), beta (ERbeta; Esr2), and Kiss1
117 e transfection of a small inhibitory RNA for ER alpha but were not affected by the small inhibitory R
119 were severely impaired in EPCs obtained from ER alpha-knockout mice (ER alphaKO) and moderately impai
120 enesis when cocultured with fibroblasts from ER-alpha(-)/PgR(-) or ER-alpha(+)/PgR(+) breast tumors;
123 on the expression of tumor suppressor genes ER-alpha and CDH1 in MDA-MB-231 breast cancer cells.
125 ent aromatase inhibitory activities and high ER-alpha and ER-beta binding affinities of several of th
128 However, the functional role of GATA-3 in ER alpha-positive breast cancers is yet to be establishe
129 4'-nitroflavone; (b) transient expression in ER alpha-negative HeLa cells of ER alpha lacking the pro
132 e was a HIF-1alpha-dependent CSC increase in ER-alpha-positive cancers following hypoxic exposure, wh
133 orm salt bridges with key lysine residues in ER-alpha (Lys(299), Lys(302), and Lys(303)), which are l
134 orm salt bridges with key lysine residues in ER-alpha (Lys-299, Lys-302, and Lys-303), which is likel
135 R-alpha), and HE4 overexpression resulted in ER-alpha downregulation in vitro and in human ovarian ca
138 e-specific transcriptional network including ER alpha and FoxA1 that dictates the phenotype of hormon
143 n neonatal uteri, prenatal arsenic increased ER-alpha expression and enhanced estrogen-related gene e
145 monstrate that nanomolar resveratrol induces ER alpha-Cav-1-c-SRC interaction, resulting in NO produc
148 f the human estrogen receptor alpha-isoform (ER alpha) with the receptor interacting domains (RIDs) o
149 t a model whereby crosstalk between liganded ER alpha and Src drives ER alpha transcriptional activit
150 between the unliganded AhR and the liganded ER alpha plays a positive role in E2-dependent activatio
152 We confirmed a role for Runx1 in mediating ER alpha genomic recruitment and regulation of tethering
153 cells was suppressed as a result of membrane ER-alpha signaling through several kinases to inhibit ca
154 nly ER-alpha (NOER) mice] or plasma membrane ER-alpha [membrane-only ER-alpha (MOER) mice], we found
156 in AJCC stage I, II, III, and IV, methylated ER-alpha was detected in 10% (2 of 20), 15% (3 of 20), 2
158 he clinical significance of serum methylated ER-alpha was assessed among AJCC stage IV melanoma patie
161 d binding domains (E domains) of human/mouse ER alpha and ER beta, progesterone receptors A and B, an
162 script in a mouse with a DNA-binding mutated ER alpha (KIKO), indicating that both Igf1 regulation an
163 We found that suppression of GPR30 but not ER-alpha prevented E2-BSA- or E2-induced PKA activation
165 We concluded that extranuclear and nuclear ER-alpha collaborate to suppress adipocyte development,
172 xpression in ER alpha-negative HeLa cells of ER alpha lacking the protein-binding domain for the AhR;
173 le rats to quantitate areas and densities of ER alpha and ER beta-positive neurons within medullary r
174 timulated breast cancer growth downstream of ER alpha and AIB1 and upstream of the cell cycle regulat
181 ods also showed that only a subpopulation of ER alpha was available to form complexes with the SRC-RI
182 rogen-activated ER alpha loss in a subset of ER alpha-negative breast cancers, altering prognosis and
183 oss age and treatment, synaptic abundance of ER-alpha is correlated with individual performance in tw
184 ion of MEK5 included increased activation of ER-alpha independent growth signaling pathways and promo
186 downregulation of expression and activity of ER-alpha and the progesterone receptor (PR), MEL-18 over
188 methylation led to an increase in binding of ER-alpha to the Hoxa10 ERE both in vitro as and in vivo
189 ChIP assay demonstrated that the binding of ER-alpha to the SNAT2 promoter gradually increased in th
190 sistance through IL-6-induced degradation of ER-alpha in luminal BrCAs.Oncogene advance online public
193 hich are potent antagonists and degraders of ER-alpha and in which the ER-alpha degrading properties
195 ata suggest that CaM-induced dimerization of ER-alpha is required for estrogen-stimulated transcripti
199 higher 2D:4D ratio, whereas inactivation of ER-alpha increases growth of digit 4, which leads to a l
200 that selectively disrupt the interaction of ER-alpha with CaM may be useful in the therapy of breast
202 rin (Lf) efficiently downregulates levels of ER-alpha, PR, and HER-2 in a proteasome-dependent manner
204 hich explains why CaM binds two molecules of ER-alpha in a 1:2 complex and stabilizes ER-alpha dimeri
205 s why full-length CaM binds two molecules of ER-alpha in a 1:2 complex and stabilizes ER-alpha dimeri
208 for understanding how the complex pattern of ER-alpha methylation and transcriptional silencing is ge
209 cells with PRL increased phosphorylation of ER-alpha at residues implicated in unliganded ER-alpha a
215 thway- specific, and the local remodeling of ER-alpha chromatin structure by pRb2/p130 multimolecular
216 gative cells rescues the BRCA1 repression of ER-alpha activity and that the E7 and E6 oncoproteins in
220 ishing and maintaining the silenced state of ER-alpha gene can be locus- or pathway- specific, and th
221 the absence of estrogen, and stimulation of ER-alpha by either Ca(2+) and/or estrogen may serve to r
222 eviously, our laboratory cloned a variant of ER-alpha, ER-alpha36, and found that ER-alpha36 mediated
224 both compete for binding at the same site on ER-alpha (residues 292, 296, 299, 302, and 303), which e
225 ] or plasma membrane ER-alpha [membrane-only ER-alpha (MOER) mice], we found that 10-wk-old mice that
226 express only nuclear ER-alpha [nuclear-only ER-alpha (NOER) mice] or plasma membrane ER-alpha [membr
227 ovariectomized wild-type mice received E2 or ER-alpha agonist propyl pyrazole triol (50 microg/25 g)
228 trauma-hemorrhage are mediated via GPR30- or ER-alpha-regulated activation of PKA-dependent signaling
229 with fibroblasts from ER-alpha(-)/PgR(-) or ER-alpha(+)/PgR(+) breast tumors; however, EIII8 cells c
230 pha(+) tamoxifen-resistant (EIII8-TAM(R)) or ER-alpha(-) MDA-MB-231 breast cancer cells to interact a
234 ed with the ability of PAK1 to phosphorylate ER-alpha on serine 305 and subsequent secondary activati
236 zed monkeys without E treatment, presynaptic ER-alpha correlated with DR accuracy across memory delay
237 PR30 versus the classical estrogen receptors ER alpha/beta and functional responses associated with l
240 transcription of HBV genes by up-regulating ER-alpha, which interacts with and alters binding of HNF
241 n sharp contrast, the more distantly related ER-alpha dimerizes so strongly that energetics can only
244 omatin immunoprecipitation analysis revealed ER alpha binding to these EREs in wild type but not KIKO
245 sion of CCN5 in SP results in EMT reversion, ER-alpha upregulation and delays in tumor growth in xeno
247 of CaM bind to the same site on two separate ER-alpha molecules (residues 292, 296, 299, 302, and 303
248 inhibition of estrogen induction of several ER alpha-associated genes, including TFF1, by HMGN1 corr
249 s were due to ER alpha or ER beta signaling, ER alpha-knockout (alphaERKO) or ERbeta-knockout (betaER
250 n (4-OHT), ICI 182 780 (Faslodex), and siRNA ER alpha indicating that the suppression is ER alpha-med
251 estern blot analysis revealed that the SNAT2 ER-alpha-ERE complex contained poly(ADP-ribose) polymera
255 romoting complex 10 activity, which targeted ER-alpha degradation through the ubiquitin-proteasome pa
258 Stat5a transcript through ERE binding; that ER alpha, either alone or together with STAT5, then acts
260 electron microscopic data demonstrating that ER-alpha is present within excitatory synapses in dorsol
262 lly, EMSAs and supershift assays showed that ER-alpha binds to the SNAT2 ERE and that this binding co
264 ough the lack of group effects suggests that ER-alpha is primarily in synapses that are stable across
266 ions associated with the MYC pathway and the ER alpha network to be among the most differential betwe
269 H1 interacts with ER alpha and increases the ER alpha-estrogen response element (ERE) interaction.
273 o cis-regulatory elements located within the ER alpha gene, and this is required for RNA polymerase I
274 10)-tri ene-3,17-diol (ICI 182,780)] and the ER-alpha- and ER-beta-specific agonists [1,3,5-tris(4-hy
276 o significantly delayed tumorigenesis in the ER-alpha-positive high premalignant line PN8a from 100%
277 cates that ER-alpha36 is a new member of the ER-alpha family that mediates membrane-initiated estroge
278 ific pRb2/p130 multimolecular complex on the ER-alpha promoter strongly correlates with the methylati
279 s and degraders of ER-alpha and in which the ER-alpha degrading properties were prospectively optimiz
281 ne whether E2-mediated responses were due to ER alpha or ER beta signaling, ER alpha-knockout (alphaE
284 n this progression from ER-alpha-positive to ER-alpha-negative lesions, we tested the ability of tamo
285 In aged monkeys that received E treatment, ER-alpha within the postsynaptic density (30-60 nm from
289 t CA12 is robustly regulated by estrogen via ER alpha in breast cancer cells, and that this regulatio
294 hniques, we show that NM23-H1 interacts with ER alpha and increases the ER alpha-estrogen response el
295 inding nucleosomal DNA, still interacts with ER alpha and, strikingly, still represses estrogen-drive
297 tumors; however, EIII8 cells cocultured with ER-alpha(-)/PgR(-) tumor-derived fibroblasts exhibited d
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。